HealthDay on MSN2d
Glucagon-Like Peptide-1 Receptor Agonists May Reduce Alcohol ConsumptionGlucagon-like peptide-1 receptor agonist (GLP-1 RA) use may reduce alcohol consumption and improve outcomes in some ...
News Medical on MSN4d
Impact of glucagon-like peptide-1 receptor agonists on alcohol consumptionThe impact of GLP-1 RAs on alcohol use is explored, showing potential benefits in reducing intake and cravings, but with ...
Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...
A recent study found that glucagon-like peptide-1 receptor (GLP-1) agonists like semaglutide and liraglutide are effective in ...
Pharmaceutical company Novo Nordisk has launched its mega-popular weight-loss drug Wegovy in China — but for a tiny fraction ...
Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle ...
A collection of studies presented at a recent American Heart Association (AHA) conference has confirmed the heart health benefits provided by the new anti-obesity drugs, semaglutide and tirzepatide, ...
Certain whole foods like oats, avocados, and lentils can mimic the effects of Ozempic, boosting the release of your GLP-1.
Popular weight loss drugs have been linked to gastrointestinal, mental health, and vision problems, but the benefits appear ...
News Medical on MSN5d
Exenatide, a GLP-1 analog, by IV during cardiac surgery did not reduce organ injury or deathA large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog ...
Inno Supps’ Trim Biome™ GLP-1 is designed to support the body’s natural production of GLP-1 through a unique blend of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback